Outlook Therapeutics Insider Trades
NASDAQ: OTLKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 10 · $7.87M
- Sales
- 0 · $0
- Shares bought / sold
- 12.00M / 0
- Net activity
- Net buying $7.9 million
Outlook Therapeutics insider activity
Over the last 12 months, Outlook Therapeutics insiders reported 10 transactions on SEC Form 4: 10 open-market purchases and 0 sales. Insiders bought $7.9 million and sold $0 worth of stock, for net insider buying of $7.9 million. The most recent filing shows Jahr Robert Charles (Chief Executive Officer) buying 151,515 shares on Aug 14, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OTLK's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
OTLK insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 14, 2026 | KENYON LAWRENCE AChief Financial Officer | Buy | 101,010 | — | Form 4 |
| Aug 14, 2026 | Jahr Robert CharlesChief Executive Officer | Buy | 151,515 | — | Form 4 |
| Aug 12, 2026 | Sukhtian Ghiath M. & GMS Ventures & InvestmentsDirector | Buy | 2,525,252 | $2.50M | Form 4 |
| Jul 29, 2026 | Sukhtian Faisal GhiathDirector | Buy | 95,398 | $100.00K | Form 4 |
| Jun 2, 2026 | Haddadin Yezan MuntherDirector | Buy | 29,000 | $24.15K | Form 4 |
| May 28, 2026 | Sukhtian Ghiath M. & GMS Ventures & InvestmentsDirector | Buy | 8,539,709 | $5.00M | Form 4 |
| May 27, 2026 | Sukhtian Faisal GhiathDirector | Buy | 122,174 | $50.01K | Form 4 |
| May 26, 2026 | THURMAN RANDY HDirector | Buy | 5,000 | $2.15K | Form 4 |
| May 26, 2026 | Haddadin Yezan MuntherDirector | Buy | 34,000 | $14.96K | Form 4 |
| May 26, 2026 | HILZINGER KURT JDirector | Buy | 400,000 | $176.52K | Form 4 |
| May 27, 2025 | Sukhtian Ghiath M. & GMS Ventures & InvestmentsDirector | Award | 4,285,714 | $6.00M | Form 4 |
| Jan 17, 2025 | Sukhtian Ghiath M. & GMS Ventures & InvestmentsDirector | Option exercise | 3,458,571 | $8.68M | Form 4 |
| Sep 26, 2024 | KENYON LAWRENCE AChief Financial Officer | Buy | 5,000 | $28.45K | Form 4 |
| Apr 15, 2024 | Syntone Ventures LLC10% Owner | Buy | 714,286 | — | Form 4 |
| Mar 28, 2024 | Haddadin Yezan MuntherDirector | Buy | 1,882 | $22.24K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4